Juan Ángel Fresno Vara

11PUBLICATIONS
24CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 10, 2026
Identification of a Muscle-Invasive Bladder Carcinoma Molecular Subtype of Poor Responders to Neoadjuvant Chemotherapy and High Expression of Targetable Biomarkers.

Lucía Trilla-Fuertes, Jorge Pedregosa-Barbas, Eugenia García-Fernández

|Sep 09, 2023
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez

|Feb 25, 2023
A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities.

Elena López-Camacho, Guillermo Prado-Vázquez, Daniel Martínez-Pérez

|Jan 08, 2023
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.

Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez

|May 28, 2022
Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics.

Lucía Trilla-Fuertes, Angelo Gámez-Pozo, María Isabel Lumbreras-Herrera

|Oct 08, 2021
Molecular characterization of triple negative breast cancer formaldehyde-fixed paraffin-embedded samples by data-independent acquisition proteomics.

Silvia García-Adrián, Lucía Trilla-Fuertes, Angelo Gámez-Pozo

Pageof 2

Frequent Collaborators

5 joint publications

Lucía Trilla-Fuertes

3 joint publications

Angelo Gámez-Pozo

2 joint publications

Paloma Maín

2 joint publications

Ricardo Ramos-Ruiz